Lucid Group announces the appointment of new CFO
April 18, 2019 | Lucid, Medical Communications, appointments, medical education
Lucid Group continues to build its infrastructure in line with its ambitious growth plans by appointing Michael Joyce as Chief Financial Officer (CFO).
Michael has considerable experience as a CFO and in finance leadership roles supporting fast-growth businesses. His skills and expertise will further strengthen the Lucid team by underpinning its growth strategy to acquire new capabilities, partnerships and companies and continue to deliver industry-leading solutions for its clients and, ultimately, patients.
Michael spent seven years at Cooper & Lybrand in the UK and Australia at the start of his career, followed by 21 years in senior finance and CFO roles within the recruitment, insurance and IT software and services industries.
Michael commented, “Lucid delivers best-in-class services to its clients and market-leading organic growth, both as a result of relentless excellence in working to improve patients’ lives. I am very excited to join Lucid at this time and be part of the great things we will achieve in the future.”
Dennis O’Brien, CEO commented, “We are delighted to welcome Michael to the team. Michael has all the experience that a fast-paced organisation like ours needs. He really gets our culture and is passionate about building an industry-leading business that will create brilliant solutions for our clients to transform patients’ lives.”
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lucid Group Appoints Former Pfizer R&D Leader Rod MacKenzie, CMG, PhD, as Board Chair to Drive Next Phase of Global Growth and Innovation
Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new proprietary insights…
Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid…
My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced…
Listen, learn and lift off
In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the…
Launch excellence
In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines…
Meet The Lucid Group Talent Team
Meet our talent team, they’re here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your…
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
Extraordinary lives: advancing change in rare diseases (Part 1)
Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on…